Pramlintide for the Treatment of Insulin-Requiring Diabetes Mellitus: Rationale and Review of Clinical Data

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.13, 2004-01, pp. : 1419-1432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pramlintide and the treatment of diabetes: a review of the data since its introduction

By Younk Lisa M Mikeladze Maia Davis Stephen N

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1439-1451

Informa Healthcare

Access to resources Recommend Favorite

Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus

Current Drug Discovery Technologies, Vol. 4, Iss. 1, 2007-01 ,pp. : 39-47

Bentham Science Publishers

Access to resources Recommend Favorite

Pramlintide a positive adjunct in type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1353-1373

Bentham Science Publishers

Access to resources Recommend Favorite

Premixed Insulin Analogues for the Treatment of Diabetes Mellitus

By Garber Alan J.

Drugs, Vol. 66, Iss. 1, 2006-01 ,pp. : 31-49

Adis International

Access to resources Recommend Favorite